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48 Insights into the transmission interfaces of human CFTR from
molecular modeling
J.-P. Mornon1, P. Lehn2, I. Callebaut1. 1CNRS − Universite´ Pierre et Marie
Curie-Paris6, UMR7590, Paris, France; 2INSERM − Universite´ de Bretagne
Occidentale, U613, Brest, France
Models of the 3D structure of full-length human CFTR described during the last
years have provided new insights into the molecular basis of CFTR functioning.
They have in particular shed light on the interdomain interfaces which are critical
for signal transmission and can thus be considered for in silico screening of
drugs (correctors and modulators) capable of ﬁlling the cavities displayed at these
interfaces in the wild type or mutated protein.
However, the modeling methodology does largely inﬂuence the characteristics of
those interdomain interfaces. Here, relying on all the available experimental data
on ABC transporters (full length and isolated domains), we show that there is
a considerable structural plasticity in these regions which allows to adapt the
partner domains. The careful consideration of such a structural plasticity in our
modeling strategy leads us to propose at present four models of human CFTR,
two (based on the Sav1866 and MsbA structures) in a similar open channel
conformation and two (based on the MsbA and P-gp structures) in notably different
closed channel conformations. We interestingly show that the global features of the
transmission interfaces [between the membrane-spanning domains (MSDs) and the
nucleotide binding domains (NBDs)] are remarkably conserved in these models
between the open and closed forms. Further investigation of the details of the
MSDs/NBDs interface also suggests that subtle differences may participate in the
general mechanisms by which the signal is transmitted between MSDs and NBDs.
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The CFTR functions as a Cl− channel and controls electrolyte transport in epithelia.
The defective synthesis and/or regulation of CFTR are implicated in two important
human diseases: Cystic Fibrosis (CF) and secretory diarrhea. CF is one the most
common lethal inherited disorders and is due to loss of function mutations in
CFTR while a disproportionately excessive response of CFTR, usually to bacterial
or viral toxins, leads to a secretory diarrhea, killing millions of kids under the
age of ﬁve throughout the world. Despite understanding that CFTR activity is
responsible for major pathology, the exact nature of the CFTR conducting pore
remains controversial, with ﬁndings pointing both to monomeric and multimeric
assembly of the CFTR. We have utilized CFTR tagged with cyan (ECFP) or yellow
(EYFP) ﬂuorescent proteins on the C or N termini. Using FRET we found no
appreciable increase in CFP ﬂuorescence after selective photobleaching of YFP,
indicative of FRET not occurring. These ﬁndings show that the cytoplasmic tails of
CFTR are not in sufﬁcient proximity for the occurrence of FRET, suggestive of a
monomeric organization of CFTR. However, upon phosphorylation and activation
of the CFTR, FRET was observed with C-terminal tags suggesting a more complex
interaction. These observations indicate that the state of the CFTR oligomerization
might not be static; rather that it might depend upon the biochemical state of the
channel or associated proteins.
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In patients with CF, the genetic errors in the cftr gene lead to a defective epithelial
Cl− transport which is proposed to be the culprit for the clinical manifestation
of CF. However, some of the transport abnormalities, Na+ hyperabsorption for
example, is hard to explain by defective Cl− transport only. Hence, in addition
to an abnormal Cl− transport as a result of a defective CFTR, understanding
other functions of the CFTR such as its regulatory role is important for the
treatment of CF airway disease. In this study we have examined the association
of ENaC subunits with mutated DF508-CFTR, the most common disease causing
mutation in CF. Deletion of phenylalanine at position 508 prevents proper processing
and targeting of CFTR to the plasma membrane. We found that ENaC subunits
could be co-immunoprecipitated with DF508-CFTR. Additionally, we evaluated
the DF508-CFTR and ENaC association by FRET. FRET efﬁciencies were not
signiﬁcantly different from negative controls suggesting that DF508-CFTR and
ENaC are not in close proximity to each other under basal conditions. However, after
partial correction of DF508-CFTR misprocessing by low temperature and chemical
rescue we observed a positive FRET signal, especially between DF508-CFTR and
b-ENaC. Our ﬁndings suggest that the mutated version of CFTR reduces the close
association of DF508-CFTR and ENaC, suggesting that rescue of Cl− transport
alone by allowing for the trafﬁcking of DF508-CFTR may not ameliorate the Na+
hyperabsorption seen in CF airway disease. This further underscores the importance
of ENaC in the pathogenesis of CF.
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Only few studies have yet described immunoblot analysis of CFTR in human
tissue. Literature data on the major cystic ﬁbrosis mutation F508del with regard
to maturation and function in human tissue are inconsistent. In the context of the
upcoming studies on correctors and potentiators of mutant CFTR it is important
to enlarge our knowledge about mutant CFTR protein biochemistry. We initiated
studies to clarify the distribution and abundance of isoforms of normal and mutant
CFTR performed both with intestine tissue and with lung tissue. Freshly excised
rectal biopsies or snap-frozen tissues from freshly explanted non-CF and CF subjects
were used for protein analysis. The outcome of both studies differed: In rectal
biopsies of homozygous F508del CF-subjects the mature complex-glycosylated
C-band of F508del CFTR was mostly detectable, albeit in different amounts, but
not in mutant lung tissue (CFTR genotypes: F508del/F508del, F508del/R553X,
F508del/deletion, homozygous 3849+10kb C-T, unknown) at this stage of global
respiratory insufﬁciency. The mannose-rich B-band was detectable in 6 of 8 lungs
and in all rectal biopsies. In conclusion, CFTR immunoblot analyses are feasible
with CF lung and rectal tissues. Both should be used to test the inﬂuence of
potentiators or correctors on the abundance and processing of mutant CFTR.
